These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 21386758

  • 1. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum.
    Finger RP, Charbel Issa P, Schmitz-Valckenberg S, Holz FG, Scholl HN.
    Retina; 2011; 31(7):1268-78. PubMed ID: 21386758
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum.
    Finger RP, Charbel Issa P, Ladewig M, Holz FG, Scholl HP.
    Br J Ophthalmol; 2008 Apr; 92(4):483-7. PubMed ID: 18369065
    [Abstract] [Full Text] [Related]

  • 3. Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a one-year prospective study.
    Finger RP, Charbel Issa P, Hendig D, Scholl HP, Holz FG.
    Am J Ophthalmol; 2011 Oct; 152(4):695-703. PubMed ID: 21704964
    [Abstract] [Full Text] [Related]

  • 4. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab.
    Teixeira A, Mattos T, Velletri R, Teixeira R, Freire J, Moares N, Bonomo PP.
    Ophthalmic Surg Lasers Imaging; 2010 Oct; 41(5):546-9. PubMed ID: 20795575
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.
    Myung JS, Bhatnagar P, Spaide RF, Klancnik JM, Cooney MJ, Yannuzzi LA, Freund KB.
    Retina; 2010 May; 30(5):748-55. PubMed ID: 19996818
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.
    Mimoun G, Caillaux V, Querques G, Rothschild PR, Puche N, Souied EH.
    Retina; 2013 Mar; 33(3):513-21. PubMed ID: 23400081
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months.
    Arevalo JF, Adan A, Berrocal MH, Espinoza JV, Maia M, Wu L, Roca JA, Quiroz-Mercado H, Ruiz-Moreno JM, Serrano MA, Pan-American Collaborative Retina Study Group.
    Retina; 2011 Feb; 31(2):353-63. PubMed ID: 20890239
    [Abstract] [Full Text] [Related]

  • 15. Results of 1-year follow-up examinations after intravitreal bevacizumab administration for idiopathic choroidal neovascularization.
    Inoue M, Kadonosono K, Watanabe Y, Sato S, Kobayashi S, Yamane S, Ito R, Arakawa A.
    Retina; 2010 May; 30(5):733-8. PubMed ID: 20168271
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intravitreal bevacizumab for treatment of subfoveal idiopathic choroidal neovascularization: results of a 1-year prospective trial.
    Zhang H, Liu ZL, Sun P, Gu F.
    Am J Ophthalmol; 2012 Feb; 153(2):300-306.e1. PubMed ID: 21982109
    [Abstract] [Full Text] [Related]

  • 18. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
    Sonmez K, Sonmez PA, Ozkan SS, Atmaca LS.
    Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results.
    Gharbiya M, Allievi F, Recupero V, Martini D, Mazzeo L, Gabrieli CB.
    Retina; 2009 Jun; 29(6):740-9. PubMed ID: 19516116
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.